Department of Microbiology and Immunology, National Liver Institute, Egypt.
Department of Hepatology and Gastroenterology, National Liver Institute, Egypt.
Expert Rev Anti Infect Ther. 2022 Jan;20(1):121-129. doi: 10.1080/14787210.2021.1935239. Epub 2021 Jun 7.
Chronic hepatitis C (CHC) is a leading cause of cirrhosis and hepatocellular carcinoma (HCC). This study aimed to study the association of IL28B, toll-like receptor (TLR) 7, cytomegalovirus and advanced liver disease.
Four groups were included; control (n = 125, 25.9%), CHC (n = 114, 23.6%), liver cirrhosis (n = 120, 24.8%), and HCC (n = 124, 25.7%).
In CHC group, patients were mainly F1 (60%) followed by F2. IL28B genotype CC percentage was higher in control group than the CHC and cirrhosis groups. CT and TT genotypes were higher in the CHC and cirrhosis groups than control group. The C allele was higher in the control group than the CHC, cirrhosis and HCC groups and the opposite with the T allele. Control and CHC had same TLR7 alleles. Cirrhosis patients and HCC had lower TLR 7 A allele and higher G allele than the control group. Both cirrhosis and HCC groups had statistically significant higher percentage of the AG and GG genotypes than the control group. Patients with HCC had higher cytomegalovirus infection percentage than cirrhosis and CHC group (38.7% vs 20% vs 16.7%), respectively.
IL28B, TLR7 SNPs and cytomegalovirus infection are risk factors for advanced liver disease in hepatitis C patients.
慢性丙型肝炎(CHC)是肝硬化和肝细胞癌(HCC)的主要原因。本研究旨在研究 IL28B、 Toll 样受体(TLR)7、巨细胞病毒与晚期肝病的相关性。
共纳入 4 组:对照组(n=125,25.9%)、CHC 组(n=114,23.6%)、肝硬化组(n=120,24.8%)和 HCC 组(n=124,25.7%)。
在 CHC 组中,患者主要为 F1(60%),其次为 F2。与 CHC 和肝硬化组相比,对照组中 IL28B 基因型 CC 的比例更高。CHC 和肝硬化组中 CT 和 TT 基因型的比例高于对照组。C 等位基因在对照组中高于 CHC、肝硬化和 HCC 组,而 T 等位基因则相反。对照组和 CHC 具有相同的 TLR7 等位基因。与对照组相比,肝硬化和 HCC 患者的 TLR7 A 等位基因较低,G 等位基因较高。无论是肝硬化还是 HCC 组,AG 和 GG 基因型的比例均明显高于对照组。与肝硬化和 CHC 组相比,HCC 组的巨细胞病毒感染比例更高(38.7%比 20%比 16.7%)。
IL28B、TLR7SNP 和巨细胞病毒感染是丙型肝炎患者发生晚期肝病的危险因素。